Recombinant Human NEU2 Protein，His

NEU2 is a sialidase, an enzyme that hydrolyzes sialic acid residues from glycoconjugates, playing a crucial role in various biological processes, including cell signaling, immune response, and pathogen recognition. Research on NEU2 has gained momentum due to its potential implications in cancer progression, neurodegenerative diseases, and viral infections, where altered sialylation patterns can affect cellular interactions and functionalities. Moreover, sialidases like NEU2 may contribute to the modulation of the tumor microenvironment and enhance the migratory capabilities of cancer cells, making them a target for therapeutic intervention. The recombinant expression of NEU2 allows for in-depth studies of its enzymatic activity, substrate specificity, and regulatory mechanisms. Recent advancements in protein engineering and expression systems have facilitated the production of active NEU2, permitting investigations into its structure-function relationships and interactions with other biomolecules. Understanding NEU2’s role in both physiological and pathological contexts is essential for developing novel strategies for disease treatment and prevention, emphasizing the importance of continued research in dissecting the functional properties of this enzyme.